Cardiac Diabetic PCD Pharma Franchise
Cardiac Diabetic PCD Pharma Franchise, the franchisee typically receives support from the franchisor in terms of marketing materials, product training, and sometimes even assistance with regulatory matters. The franchisee then sells the products directly to healthcare providers such as hospitals, clinics, and pharmacies within their designated territory.
Elkos Healthcare Pvt. Ltd.
Elkos Healthcare is an emerging Cardiac Diabetic PCD franchise company in India. We are manufacturing and delivering a wide range of Cardiac Diabetic PCD Products. Our team is experts in drug formulations solution as per WHO and GMP authorize units. We are fulfilling the high demand and conditions of the massive population by obtaining a highly effective and anti-diabetic product range. As the heart and diabetes infections are growing our product range is also expanding. A Cardiac Diabetic PCD Pharma Franchise is a business arrangement where a pharmaceutical company grants distribution and marketing rights for cardiac and diabetic products to another party (franchisee) within a specific geographic area.
Contact number: +91-96930-22222
Website: www.elkosgroup.in
Email: elkos7777@gmail.com
Address: Plot NO.246 HSIIDC Industrial EstateAlipur, Barwala, Panchkula-134118 Haryana, India.
( Cardiac Diabetic PCD Products List )
TABLETS/CAPSULES
| S.N | Brand Name | Composition | Pack | Style |
|---|---|---|---|---|
| 1. | ROSUFED-10 | Rosuvastatin 10 mg | 10*10 | TABLET |
| 2. | ROSUFED-20 | Rosuvastatin 20 mg | 10*10 | TABLET |
| 3. | GLYKOS-500 | Metformin 500 mg SR (Clear Pvc) | 20*10 | TABLET |
| 4. | TELMIFED-CL | Cilnidipine 10 mg + Telmisartan 40 mg (DRS 15’S Dye) | 10*5 | TABLET |
| 5. | TELMIFED-CH | Telmisartan 40 mg + Chlorthalidone 12.5 mg (DRS 15’S Die) | 10*15 | TABLET |
| 6. | METOFED-25 | Metoprolol Succinate ER 25 mg | 10*10 | TABLET |
| 7. | METOFED-50 | Metoprolol Succinate ER 50 mg | 10*10 | TABLET |
| 8. | TELMIFED-AH | Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.5 mg (DRS Dye) | 10*15 | TABLET |
| 9. | TELMIFED-TRIO | Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg | 10*10 | TABLET |
| 10. | DAPAFED-10 | Dapagliflozin 10 mg | 10*14 | TABLET |
| 11. | KOSNIB-5 | Tofacitinib 5 mg (PRC JOB WITH COPPER COLOR PVC) | 10*10 | TABLET |
| 12. | DAPAFED-M 10/500 | Dapagliflozin 10 mg + Metformin Hydrochloride (ER) 500 mg) | 10*10 | TABLET |
| 13. | TELMIFED BETA-25 | Metoprolol Succinate ER 25 mg + Telmisartan 40 mg (Bilayered) | 10*10 | TABLET |
| 14. | TELMIFED BETA-50 | Metoprolol Succinate ER 50 mg + Telmisartan 40 mg (Bilayered) | 10*10 | TABLET |
| 15. | NITROFED-100 | Nitrofurantoin Sustained Release 100 mg | 10*14 | TABLET |
| 16. | DAPAFED-V 10/100 | Vildagliptin (SR) 100 mg + Dapagliflozin 10 mg | 10*10 | TABLET |
| 17. | VALKOS-50 | Sacubitril 24 mg + Valsartan 26 mg Tablets (50 mg) | 10*14 | TABLET |
| 18. | LINAFED-D 5/10 | Linagliptin 5 mg + Dapagliflozin 10 mg | 10*10 | TABLET |
| 19. | TELMIFED-XL TRIO | Metoprolol Succinate ER 50 mg + Cilnidipine 10 mg + Telmisartan 40 mg (DRS 15’S Dye) | 10*15 | TABLET |
| 20. | LINAFED-5 | Linagliptin 5 mg (PRC Job, Peach PVC) | 10*10 | TABLET |
| 21. | LINAFED-M 2.5/500 | Linagliptin 2.5 mg + Metformin 500 mg (White PVC) | 10*10 | TABLET |
| 22. | ACODOM-100 | Acotiamide 100 mg (Scored Tab) | 10*10 | TABLET |
| 23. | SITACOB-DM 100/10/500 | Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin (ER) 500 mg | 10*10 | TABLET |
| 24. | RENATOX | Alpha Ketoanalogues and Essential Amino Acids (Golden Base Foil) | 10*10 | TABLET |
| 25. | SITACOB-M 50/500 | Sitagliptin 50 mg + Metformin 500 mg (Milky PVC, 0.35mm) | 10*15 | TABLET |
| 26. | SITACOB-D 100/10 | Dapagliflozin 10 mg + Sitagliptin 100 mg | 10*10 | TABLET |
| 27. | SITACOB-50 | Sitagliptin 50 mg (Milky PVC, 0.35mm) | 10*7 | TABLET |
| 28. | ATORGET-GOLD 20 | Atorvastatin 20 mg + Clopidogrel 75 mg + Aspirin 75 mg | 10*10 | CAPSULE |
| 29. | ATORGET-A 10/75 | Atorvastatin 10 mg + Aspirin 75 mg | 10*10 | CAPSULE |
| 30. | ROSUFED-A 10/75 | Rosuvastatin 10 mg + Aspirin 75 mg | 10*10 | CAPSULE |
| 31. | FLAVODOX-200 | Flavoxate 200 mg | 10*15 | TABLET |
| 32. | AMLOWIK-AT | Amlodipine Besilate 5mg+Atenolol | 50mg | TABLET |
| 33. | AMTROXIN-25 | Thyroxin 25mcg Tablet | 120 Tab+HDPE | TABLET |
| 34. | AMTROXIN-50 | Thyroxin 50mcg Tablet | 120 Tab+HDPE | TABLET |
| 35. | AMTROXIN-100 | Thyroxine 100mcg Tablet | 120 Tab+HDPE | TABLET |
| 36. | AMCONTIN-2.6 | Nitroglycerine 2.6mg Tablet | 30 Tab+HDPE | TABLET |
| 37. | AMCONTIN-6.4 | Nitroglycerine 6.4mg Tablet | 30 Tab+HDPE | TABLET |
| 38. | ATORGET-10 | Atorvastatin 10mg Tablet | 10*15 | TABLET |
| 39. | ATORGET-20 | Atorvastatin 20mg Tablet | 10*15,alu/alu | TABLET |
| 40. | ATORGET-40 | Atorvastatin 40mg | 10*10,alu/alu | TABLET |
| 41. | ATORGET-F | Atorvastatin Calcium 10mg+Fenofibrate | 10*10 | TABLET |
| 42. | ATORGET GOLD-10 | Atorvastatin Calcium 10mg+Clopidogrel 75mg+Aspirin Capsule | 10*10 | Capsule |
| 43. | ATORGET GOLD-20 | Atorvastatin Calcium 20mg+Clopidogrel 75mg+Aspirin | 10*10 | Capsule |
| 44. | CLOPIKOS | Clopidogrel 75mg | 10*10 | TABLET |
| 45. | CLOPIKOS-A75 | Clopidogrel 75mg+Aspirin 75mg | 10*10 | Capsule |
| 46. | DAPAFED-S | Dapagliflozin 10mg+Sitagliptine 100mg | 10*10 | TABLET |
| 47. | DAPAFED-SM | Dapagliflozin 10mg+Sitagliptine 100mg+ Metformin 500mg | 10*10 | TABLET |
| 48. | GLYKOS-500 | Metformine(SR) 500mg | 20*10 | TABLET |
| 49. | GLYKOS-1000 | Metformine(SR) 1000mg | 10*15 | TABLET |
| 50. | GLYKOS-G1 | Metformine(SR)500mg+Glimepiride 1mg Bilayered | 10*15 | TABLET |
| 51. | GLYKOS-G2 | Metformine(SR)500mg+Glimepiride 2mg Bilayered | 10*15 | TABLET |
| 52. | GLYKOS-GP1 | Metformine 500mg+Pioglitazone 15mg +Glimepiride 1mg Bilayered | 10*15 | TABLET |
| 53. | GLYKOS-GP2 | Metformine 500mg+Pioglitazone 15mg+Glimepiride 2mg Bilayered | 10*15 | TABLET |
| 54. | GLYKOS-M | Gliclazide 80mg +Metformine(SR)500mg Tablet | 10*15 | TABLET |
| 55. | KOSLIP-20 | Tenegliptin 20mg | 10*10 | TABLET |
| 56. | KOSLIP-M500 | Tenegliptin 20mg+Metformine 500mg | 10*10 | TABLET |
| 57. | KOSPRIDE-1 | Glimepride 1mg | 2*5*15 | TABLET |
| 58. | KOSPRIDE-2 | Glimepride 2mg | 2*5*15 | TABLET |
| 59. | LOMIFED-50 | Losartan Potassium 50mg | 10*150 | TABLET |
| 60. | METOFED-25 T | Metoprolol 25mg+Telmisartan 40mg | 10*10 | TABLET |
| 61. | DAPAFED-SM | Dapagliflozin 10mg+Sitagliptine 100mg+ Metformin 500mg | 10*10 | TABLET |
| 62. | METOFED-50 T | Metoprolol 50mg+Telmisartan 40mg | 10*10 | TABLET |
| 63. | METOFED TRIO | Metoprolol 50mg+Cilnidipine 10mg+Telmisartan 40mg | 10*15 | TABLET |
| 64. | OLMIFED-20 | Olmesartan Medoxomil 20mg | 10*10 | TABLET |
| 65. | OLMIFED-40 | Olmesartan Medoxomil 40mg | 10*10 | TABLET |
| 66. | OLMIFED-H | Olmesartan Medoxomil 40mg+Hydrochlorothiazide | 10*15 | TABLET |
| 67. | ROSUFED GOLD-10 | Rosuvastatin 10mg+Aspirin 75mg+Clopidogrel 75mg | 10*10 | Capsule |
| 68. | ROSUFED GOLD-20 | Rosuvastatin 20mg+Aspirin 75mg+Clopidogrel 75mg | 10*10 | capsule |
| 69. | ROSUFED-F | Rosuvastatin 10mg+Fenofibrate 160mg | 10*10 | TABLET |
| 70. | TELMIFED-40 | Telmisartan 40mg | 10*15 | TABLET |
| 71. | TELMIFED-AM | Telmisartan 40mg+Amlodipine 5mg | 10*15 | TABLET |
| 72. | TELMIFED-40HT | Telmisartan 40mg+Hydrochlorothiazide 12.5mg | 10*15 | TABLET |
| 73. | TELMIFED TRIO | Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg | 10*10 | TABLET |
| 74. | VILDAKOS-50 | Vildagliptin 50mg | 10*10 | TABLET |
| 75. | VILDAKOS-M 1000 | Vildagliptin 50mg+Metformine 1000mg | 10*10 | TABLET |
| 76. | VOPRIDE-2 | Voglibose 0.2mg | 10*10 | TABLET |
| 77. | VOPRIDE-3 | Voglibose 0.3mg | 10*10 | TABLET |
| 78. | VOPRIDE-MG1 | Voglibose 0.2mg+Glimepiride 1mg+Metformine 500mg SR | 10*10 | TABLET |
| 79. | VOPRIDE-MG2 | Voglibose 0.2mg+Glimepiride 2mg+Metformine 500mg SR | 10*10 | TABLET |
Advantages of Collaborating with Cardiac Diabetic Franchise Company
1). Expertise and Experience:
Elkos Healthcare has specialized knowledge and experience in dealing with cardiac and diabetic products. They understand the nuances of these conditions, their treatments, and the preferences of healthcare providers and patients.
2). Expertise and Experience:
Partnering with a Elkos Healthcare gives you access to an established brand name in the cardiac diabetic market. This can lend credibility to your products and services, making it easier to gain trust from healthcare professionals and patients.
3). Distribution Network:
Franchise companies typically have a well-established distribution network, including relationships with hospitals, clinics, pharmacies, and other healthcare facilities. This can significantly expedite the process of getting your products into the hands of those who need them.
4). Marketing Support:
Elkos Healthcare provides marketing support, including advertising materials, promotional campaigns, and sales training. This support can help you effectively promote your products and reach your target audience.
collaborating with a cardiac diabetic franchise company can provide you with a strategic advantage, helping you penetrate the market more effectively and efficiently while mitigating risks associated with entering a highly specialized industry.
What is the scope of Cardiac Diabetic Franchise?
The scope of a Cardiac Diabetic Franchise can be quite extensive, considering the prevalence of cardiac and diabetic conditions globally.
1). Market Demand:
Cardiovascular diseases and diabetes are among the leading causes of morbidity and mortality worldwide. With the rise in sedentary lifestyles, poor dietary habits, and aging populations, the demand for medications, devices, and diagnostic tools related to these conditions remains high.
2). Diverse Product Range:
A Cardiac Diabetic Franchise can encompass a wide range of products, including medications for hypertension, dyslipidemia, diabetes, and heart failure, as well as devices like glucose meters, blood pressure monitors, and cardiac monitoring equipment.
3). Collaborations and Partnerships:
Collaborations with hospitals, clinics, pharmacies, and healthcare professionals can expand the reach of the franchise. Partnerships with pharmaceutical companies for research and development or distribution agreements can also enhance the franchise’s offerings.
The scope of a Cardiac Diabetic Franchise is broad, encompassing various aspects of healthcare delivery, product development, education, and technological integration aimed at addressing the growing burden of cardiac and diabetic diseases.
(F.A.Q.)
What is a Cardiac Diabetic PCD Pharma Franchise?
A Cardiac Diabetic PCD Pharma Franchise is a business arrangement where a pharmaceutical company grants distribution and marketing rights for cardiac and diabetic products to another party (franchisee) within a specific geographic area.
What are the benefits of starting a Cardiac Diabetic PCD Pharma Franchise?
a). Established brand name and products.
b). Support from the franchisor in terms of marketing, training, and sometimes regulatory matters.
c). Opportunity to enter the pharmaceutical market with specialized products.
d). Potential for profit in growing markets for cardiac and diabetic medications.
How can I apply for a Cardiac Diabetic PCD Pharma Franchise?
You can apply by contacting pharmaceutical companies offering Cardiac Diabetic PCD franchises. Reach out to them through their websites or industry directories and express your interest in becoming a franchisee.
What are the requirements to start a Cardiac Diabetic PCD Pharma Franchise?
a). Adequate financial resources for initial investment and ongoing operations.
b). Commitment to adhere to franchise agreements and regulatory requirements.
c). Access to necessary infrastructure for distribution and storage of pharmaceutical products.
Is there a minimum investment required to start a Cardiac Diabetic PCD Pharma Franchise?
Yes, there may be a minimum investment required, which can vary depending on the franchisor and the size of the territory.
How are profits shared in a Cardiac Diabetic PCD Pharma Franchise?
Profit-sharing arrangements vary between franchisors. Typically, the franchisee retains a portion of the profits generated from sales, while the remaining portion goes to the franchisor as royalties or fees.
How can I ensure success as a Cardiac Diabetic PCD Pharma Franchisee?
Success often depends on factors such as effective marketing and sales strategies, strong customer relationships, adherence to regulatory requirements, and staying updated on developments in the pharmaceutical industry. Additionally, maintaining high standards of service and product quality can help build a positive reputation and attract more customers.